"EMA-CO regimen" is useful in Rx of: (A) Metastatic breast cancer, (B) Advanced endometrial sarcoma, (C) Gestational trophoblastic neoplasia, (D) Ovarian tumor with peritoneal implants
Answer is C. EMA-CO a cyclic non-cross-resistant combina on of etoposide, methotrexate, and dactinomycin alternating with cyclophosphamide and vincristine.